Global Heparin Active Pharmaceutical Ingredients Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 107
Published Date: 09 Jan 2023
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
According to our (Global Info Research) latest study, the global Heparin Active Pharmaceutical Ingredients market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Heparin Active Pharmaceutical Ingredients market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Heparin Active Pharmaceutical Ingredients market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Heparin Active Pharmaceutical Ingredients market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Heparin Active Pharmaceutical Ingredients market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Heparin Active Pharmaceutical Ingredients market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heparin Active Pharmaceutical Ingredients
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Heparin Active Pharmaceutical Ingredients market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Heparin Active Pharmaceutical Ingredients market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Heparin Sodium
Heparin Calcium
Other
Market segment by Application
Unfractionated Heparin
Low Molecular Heparin
Major players covered
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin Active Pharmaceutical Ingredients product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin Active Pharmaceutical Ingredients, with price, sales, revenue and global market share of Heparin Active Pharmaceutical Ingredients from 2018 to 2023.
Chapter 3, the Heparin Active Pharmaceutical Ingredients competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin Active Pharmaceutical Ingredients breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Heparin Active Pharmaceutical Ingredients market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin Active Pharmaceutical Ingredients.
Chapter 14 and 15, to describe Heparin Active Pharmaceutical Ingredients sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Heparin Active Pharmaceutical Ingredients
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Heparin Active Pharmaceutical Ingredients Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Heparin Sodium
1.3.3 Heparin Calcium
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Heparin Active Pharmaceutical Ingredients Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Unfractionated Heparin
1.4.3 Low Molecular Heparin
1.5 Global Heparin Active Pharmaceutical Ingredients Market Size & Forecast
1.5.1 Global Heparin Active Pharmaceutical Ingredients Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Heparin Active Pharmaceutical Ingredients Sales Quantity (2018-2029)
1.5.3 Global Heparin Active Pharmaceutical Ingredients Average Price (2018-2029)
2.1 Hepalink
2.1.1 Hepalink Details
2.1.2 Hepalink Major Business
2.1.3 Hepalink Heparin Active Pharmaceutical Ingredients Product and Services
2.1.4 Hepalink Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hepalink Recent Developments/Updates
2.2 Changshan Pharm
2.2.1 Changshan Pharm Details
2.2.2 Changshan Pharm Major Business
2.2.3 Changshan Pharm Heparin Active Pharmaceutical Ingredients Product and Services
2.2.4 Changshan Pharm Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Changshan Pharm Recent Developments/Updates
2.3 Qianhong Bio-pharma
2.3.1 Qianhong Bio-pharma Details
2.3.2 Qianhong Bio-pharma Major Business
2.3.3 Qianhong Bio-pharma Heparin Active Pharmaceutical Ingredients Product and Services
2.3.4 Qianhong Bio-pharma Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Qianhong Bio-pharma Recent Developments/Updates
2.4 Opocrin
2.4.1 Opocrin Details
2.4.2 Opocrin Major Business
2.4.3 Opocrin Heparin Active Pharmaceutical Ingredients Product and Services
2.4.4 Opocrin Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Opocrin Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Heparin Active Pharmaceutical Ingredients Product and Services
2.5.4 Pfizer Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer Recent Developments/Updates
2.6 Aspen Oss
2.6.1 Aspen Oss Details
2.6.2 Aspen Oss Major Business
2.6.3 Aspen Oss Heparin Active Pharmaceutical Ingredients Product and Services
2.6.4 Aspen Oss Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aspen Oss Recent Developments/Updates
2.7 King-friend Biochemical Pharmaceutical
2.7.1 King-friend Biochemical Pharmaceutical Details
2.7.2 King-friend Biochemical Pharmaceutical Major Business
2.7.3 King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product and Services
2.7.4 King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 King-friend Biochemical Pharmaceutical Recent Developments/Updates
2.8 Bioibérica
2.8.1 Bioibérica Details
2.8.2 Bioibérica Major Business
2.8.3 Bioibérica Heparin Active Pharmaceutical Ingredients Product and Services
2.8.4 Bioibérica Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bioibérica Recent Developments/Updates
2.9 Dongcheng Biochemicals
2.9.1 Dongcheng Biochemicals Details
2.9.2 Dongcheng Biochemicals Major Business
2.9.3 Dongcheng Biochemicals Heparin Active Pharmaceutical Ingredients Product and Services
2.9.4 Dongcheng Biochemicals Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Dongcheng Biochemicals Recent Developments/Updates
2.10 Jiulong Biochemicals
2.10.1 Jiulong Biochemicals Details
2.10.2 Jiulong Biochemicals Major Business
2.10.3 Jiulong Biochemicals Heparin Active Pharmaceutical Ingredients Product and Services
2.10.4 Jiulong Biochemicals Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiulong Biochemicals Recent Developments/Updates
2.11 Tiandong
2.11.1 Tiandong Details
2.11.2 Tiandong Major Business
2.11.3 Tiandong Heparin Active Pharmaceutical Ingredients Product and Services
2.11.4 Tiandong Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tiandong Recent Developments/Updates
2.12 Xinbai
2.12.1 Xinbai Details
2.12.2 Xinbai Major Business
2.12.3 Xinbai Heparin Active Pharmaceutical Ingredients Product and Services
2.12.4 Xinbai Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Xinbai Recent Developments/Updates
2.13 Yino Pharma Limited
2.13.1 Yino Pharma Limited Details
2.13.2 Yino Pharma Limited Major Business
2.13.3 Yino Pharma Limited Heparin Active Pharmaceutical Ingredients Product and Services
2.13.4 Yino Pharma Limited Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Yino Pharma Limited Recent Developments/Updates
2.14 Deebio
2.14.1 Deebio Details
2.14.2 Deebio Major Business
2.14.3 Deebio Heparin Active Pharmaceutical Ingredients Product and Services
2.14.4 Deebio Heparin Active Pharmaceutical Ingredients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Deebio Recent Developments/Updates
3.1 Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Manufacturer (2018-2023)
3.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Manufacturer (2018-2023)
3.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Heparin Active Pharmaceutical Ingredients by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Heparin Active Pharmaceutical Ingredients Manufacturer Market Share in 2022
3.4.2 Top 6 Heparin Active Pharmaceutical Ingredients Manufacturer Market Share in 2022
3.5 Heparin Active Pharmaceutical Ingredients Market: Overall Company Footprint Analysis
3.5.1 Heparin Active Pharmaceutical Ingredients Market: Region Footprint
3.5.2 Heparin Active Pharmaceutical Ingredients Market: Company Product Type Footprint
3.5.3 Heparin Active Pharmaceutical Ingredients Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Heparin Active Pharmaceutical Ingredients Market Size by Region
4.1.1 Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2018-2029)
4.1.2 Global Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2018-2029)
4.1.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2018-2029)
4.2 North America Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029)
4.3 Europe Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029)
4.4 Asia-Pacific Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029)
4.5 South America Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029)
4.6 Middle East and Africa Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029)
5.1 Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2029)
5.2 Global Heparin Active Pharmaceutical Ingredients Consumption Value by Type (2018-2029)
5.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2018-2029)
6.1 Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2029)
6.2 Global Heparin Active Pharmaceutical Ingredients Consumption Value by Application (2018-2029)
6.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2018-2029)
7.1 North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2029)
7.2 North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2029)
7.3 North America Heparin Active Pharmaceutical Ingredients Market Size by Country
7.3.1 North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2029)
7.3.2 North America Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2029)
8.2 Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2029)
8.3 Europe Heparin Active Pharmaceutical Ingredients Market Size by Country
8.3.1 Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2029)
8.3.2 Europe Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Heparin Active Pharmaceutical Ingredients Market Size by Region
9.3.1 Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2029)
10.2 South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2029)
10.3 South America Heparin Active Pharmaceutical Ingredients Market Size by Country
10.3.1 South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2029)
10.3.2 South America Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Heparin Active Pharmaceutical Ingredients Market Size by Country
11.3.1 Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Heparin Active Pharmaceutical Ingredients Market Drivers
12.2 Heparin Active Pharmaceutical Ingredients Market Restraints
12.3 Heparin Active Pharmaceutical Ingredients Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Heparin Active Pharmaceutical Ingredients and Key Manufacturers
13.2 Manufacturing Costs Percentage of Heparin Active Pharmaceutical Ingredients
13.3 Heparin Active Pharmaceutical Ingredients Production Process
13.4 Heparin Active Pharmaceutical Ingredients Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Heparin Active Pharmaceutical Ingredients Typical Distributors
14.3 Heparin Active Pharmaceutical Ingredients Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Hepalink Basic Information, Manufacturing Base and Competitors
Table 4. Hepalink Major Business
Table 5. Hepalink Heparin Active Pharmaceutical Ingredients Product and Services
Table 6. Hepalink Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Hepalink Recent Developments/Updates
Table 8. Changshan Pharm Basic Information, Manufacturing Base and Competitors
Table 9. Changshan Pharm Major Business
Table 10. Changshan Pharm Heparin Active Pharmaceutical Ingredients Product and Services
Table 11. Changshan Pharm Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Changshan Pharm Recent Developments/Updates
Table 13. Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
Table 14. Qianhong Bio-pharma Major Business
Table 15. Qianhong Bio-pharma Heparin Active Pharmaceutical Ingredients Product and Services
Table 16. Qianhong Bio-pharma Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Qianhong Bio-pharma Recent Developments/Updates
Table 18. Opocrin Basic Information, Manufacturing Base and Competitors
Table 19. Opocrin Major Business
Table 20. Opocrin Heparin Active Pharmaceutical Ingredients Product and Services
Table 21. Opocrin Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Opocrin Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Heparin Active Pharmaceutical Ingredients Product and Services
Table 26. Pfizer Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Pfizer Recent Developments/Updates
Table 28. Aspen Oss Basic Information, Manufacturing Base and Competitors
Table 29. Aspen Oss Major Business
Table 30. Aspen Oss Heparin Active Pharmaceutical Ingredients Product and Services
Table 31. Aspen Oss Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Aspen Oss Recent Developments/Updates
Table 33. King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. King-friend Biochemical Pharmaceutical Major Business
Table 35. King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product and Services
Table 36. King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 38. Bioibérica Basic Information, Manufacturing Base and Competitors
Table 39. Bioibérica Major Business
Table 40. Bioibérica Heparin Active Pharmaceutical Ingredients Product and Services
Table 41. Bioibérica Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bioibérica Recent Developments/Updates
Table 43. Dongcheng Biochemicals Basic Information, Manufacturing Base and Competitors
Table 44. Dongcheng Biochemicals Major Business
Table 45. Dongcheng Biochemicals Heparin Active Pharmaceutical Ingredients Product and Services
Table 46. Dongcheng Biochemicals Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Dongcheng Biochemicals Recent Developments/Updates
Table 48. Jiulong Biochemicals Basic Information, Manufacturing Base and Competitors
Table 49. Jiulong Biochemicals Major Business
Table 50. Jiulong Biochemicals Heparin Active Pharmaceutical Ingredients Product and Services
Table 51. Jiulong Biochemicals Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiulong Biochemicals Recent Developments/Updates
Table 53. Tiandong Basic Information, Manufacturing Base and Competitors
Table 54. Tiandong Major Business
Table 55. Tiandong Heparin Active Pharmaceutical Ingredients Product and Services
Table 56. Tiandong Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tiandong Recent Developments/Updates
Table 58. Xinbai Basic Information, Manufacturing Base and Competitors
Table 59. Xinbai Major Business
Table 60. Xinbai Heparin Active Pharmaceutical Ingredients Product and Services
Table 61. Xinbai Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Xinbai Recent Developments/Updates
Table 63. Yino Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 64. Yino Pharma Limited Major Business
Table 65. Yino Pharma Limited Heparin Active Pharmaceutical Ingredients Product and Services
Table 66. Yino Pharma Limited Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Yino Pharma Limited Recent Developments/Updates
Table 68. Deebio Basic Information, Manufacturing Base and Competitors
Table 69. Deebio Major Business
Table 70. Deebio Heparin Active Pharmaceutical Ingredients Product and Services
Table 71. Deebio Heparin Active Pharmaceutical Ingredients Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Deebio Recent Developments/Updates
Table 73. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Manufacturer (2018-2023) & (Kiloton)
Table 74. Global Heparin Active Pharmaceutical Ingredients Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Heparin Active Pharmaceutical Ingredients Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 76. Market Position of Manufacturers in Heparin Active Pharmaceutical Ingredients, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Heparin Active Pharmaceutical Ingredients Production Site of Key Manufacturer
Table 78. Heparin Active Pharmaceutical Ingredients Market: Company Product Type Footprint
Table 79. Heparin Active Pharmaceutical Ingredients Market: Company Product Application Footprint
Table 80. Heparin Active Pharmaceutical Ingredients New Market Entrants and Barriers to Market Entry
Table 81. Heparin Active Pharmaceutical Ingredients Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2018-2023) & (Kiloton)
Table 83. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2024-2029) & (Kiloton)
Table 84. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2018-2023) & (US$/Ton)
Table 87. Global Heparin Active Pharmaceutical Ingredients Average Price by Region (2024-2029) & (US$/Ton)
Table 88. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2023) & (Kiloton)
Table 89. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2024-2029) & (Kiloton)
Table 90. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2018-2023) & (US$/Ton)
Table 93. Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2024-2029) & (US$/Ton)
Table 94. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2023) & (Kiloton)
Table 95. Global Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2024-2029) & (Kiloton)
Table 96. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2018-2023) & (US$/Ton)
Table 99. Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2024-2029) & (US$/Ton)
Table 100. North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2023) & (Kiloton)
Table 101. North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2024-2029) & (Kiloton)
Table 102. North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2023) & (Kiloton)
Table 103. North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2024-2029) & (Kiloton)
Table 104. North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2023) & (Kiloton)
Table 105. North America Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2024-2029) & (Kiloton)
Table 106. North America Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2023) & (Kiloton)
Table 109. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2024-2029) & (Kiloton)
Table 110. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2023) & (Kiloton)
Table 111. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2024-2029) & (Kiloton)
Table 112. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2023) & (Kiloton)
Table 113. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2024-2029) & (Kiloton)
Table 114. Europe Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2023) & (Kiloton)
Table 117. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2024-2029) & (Kiloton)
Table 118. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2023) & (Kiloton)
Table 119. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2024-2029) & (Kiloton)
Table 120. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2018-2023) & (Kiloton)
Table 121. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2024-2029) & (Kiloton)
Table 122. Asia-Pacific Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2023) & (Kiloton)
Table 125. South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2024-2029) & (Kiloton)
Table 126. South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2023) & (Kiloton)
Table 127. South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2024-2029) & (Kiloton)
Table 128. South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2018-2023) & (Kiloton)
Table 129. South America Heparin Active Pharmaceutical Ingredients Sales Quantity by Country (2024-2029) & (Kiloton)
Table 130. South America Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Heparin Active Pharmaceutical Ingredients Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2018-2023) & (Kiloton)
Table 133. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Type (2024-2029) & (Kiloton)
Table 134. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2018-2023) & (Kiloton)
Table 135. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Application (2024-2029) & (Kiloton)
Table 136. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2018-2023) & (Kiloton)
Table 137. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity by Region (2024-2029) & (Kiloton)
Table 138. Middle East & Africa Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Heparin Active Pharmaceutical Ingredients Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Heparin Active Pharmaceutical Ingredients Raw Material
Table 141. Key Manufacturers of Heparin Active Pharmaceutical Ingredients Raw Materials
Table 142. Heparin Active Pharmaceutical Ingredients Typical Distributors
Table 143. Heparin Active Pharmaceutical Ingredients Typical Customers
List of Figures
Figure 1. Heparin Active Pharmaceutical Ingredients Picture
Figure 2. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Type in 2022
Figure 4. Heparin Sodium Examples
Figure 5. Heparin Calcium Examples
Figure 6. Other Examples
Figure 7. Global Heparin Active Pharmaceutical Ingredients Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Application in 2022
Figure 9. Unfractionated Heparin Examples
Figure 10. Low Molecular Heparin Examples
Figure 11. Global Heparin Active Pharmaceutical Ingredients Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Heparin Active Pharmaceutical Ingredients Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Heparin Active Pharmaceutical Ingredients Sales Quantity (2018-2029) & (Kiloton)
Figure 14. Global Heparin Active Pharmaceutical Ingredients Average Price (2018-2029) & (US$/Ton)
Figure 15. Global Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Heparin Active Pharmaceutical Ingredients by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Heparin Active Pharmaceutical Ingredients Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Heparin Active Pharmaceutical Ingredients Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Heparin Active Pharmaceutical Ingredients Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Heparin Active Pharmaceutical Ingredients Average Price by Type (2018-2029) & (US$/Ton)
Figure 30. Global Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Heparin Active Pharmaceutical Ingredients Average Price by Application (2018-2029) & (US$/Ton)
Figure 33. North America Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Region (2018-2029)
Figure 53. China Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Heparin Active Pharmaceutical Ingredients Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Heparin Active Pharmaceutical Ingredients Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Heparin Active Pharmaceutical Ingredients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Heparin Active Pharmaceutical Ingredients Market Drivers
Figure 74. Heparin Active Pharmaceutical Ingredients Market Restraints
Figure 75. Heparin Active Pharmaceutical Ingredients Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Heparin Active Pharmaceutical Ingredients in 2022
Figure 78. Manufacturing Process Analysis of Heparin Active Pharmaceutical Ingredients
Figure 79. Heparin Active Pharmaceutical Ingredients Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Hepalink Changshan Pharm Qianhong Bio-pharma Opocrin Pfizer Aspen Oss King-friend Biochemical Pharmaceutical Bioibérica Dongcheng Biochemicals Jiulong Biochemicals Tiandong Xinbai Yino Pharma Limited Deebio
Related Reports
10 Feb 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
